2020 ASCO Virtual Direct™ Highlights

 

Lung
08:15

2020 ASCO Virtual Direct™ Highlights

2020 Update on Radiation Therapy in Lung Cancer: Is High-Dose Twice-Daily TRT More Effective vs. Standard-Dose in LS-SCLC? Did Pembro + CCRT Show Promising Antitumor Activity in Unresectable Stage III NSCLC?

FEATURING Hossein Borghaei
  • 327 views
  • August 24, 2020
  • 3
10:59

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Targeted Therapy in NSCLC: Is Adjuvant Osimertinib Highly Effective and Practice Changing in Stage IB/II/IIIA EGFRm NSCLC After Complete Tumor Resection?

FEATURING Hossein Borghaei
  • 438 views
  • August 6, 2020
  • 1
06:00

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Targeted Therapy in mNSCLC: Is Trastuzumab Deruxtecan a Promising New Therapy for HER2+? How Beneficial Is Erlotinib + Bevacizumab in EGFR+ Disease?

FEATURING Ryan Gentzler
  • 76 views
  • August 24, 2020
03:50

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Lung Cancer Management During COVID-19: What Is the Impact of Cancer Therapy and COVID-19 Therapy on Survival?

FEATURING Ryan Gentzler
  • 9 views
  • August 24, 2020
12:36

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on IO in mNSCLC: Should We Still Consider Chemotherapy Alone as a SoC? Is There a Benefit to Ipi/Nivo Combos Over Chemo + PD-1 Approach?

FEATURING Ryan Gentzler
  • 355 views
  • August 4, 2020
08:41

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on ES-SCLC: Does the Addition of Tremelimumab to Durvalumab + Chemo Provide Additional Benefit?

FEATURING Ryan Gentzler
  • 184 views
  • August 4, 2020
  • 1